What are the differential diagnoses for a patient presenting with hypercalcemia, renal failure, bone pain, and hypertension?

Differential Diagnosis: Hypercalcemia, Renal Failure, Bone Pain, and Hypertension

The combination of hypercalcemia, renal failure, bone pain, and hypertension most commonly indicates either primary hyperparathyroidism or hypercalcemia of malignancy, with multiple myeloma being the most critical malignancy to exclude given the constellation of CRAB features (hypercalcemia, renal dysfunction, anemia, bone lesions). 1, 2

Primary Diagnostic Considerations

1. Malignancy-Related Hypercalcemia (Most Urgent)

Hypercalcemia of malignancy accounts for up to 65% of hypercalcemic patients in hospitalized settings and carries poor prognosis if untreated 2. The specific malignancies to prioritize include:

• Multiple Myeloma: The CRAB features (hypercalcemia, renal dysfunction, anemia, bone lesions) are classic, though not specific 3. Check serum and urine protein electrophoresis, serum free light chains, and bone marrow biopsy if suspicion is high.

• Solid Tumors: Squamous cell carcinomas (lung, head/neck), breast cancer, and renal cell carcinoma commonly cause humoral hypercalcemia via PTHrP secretion 2. Look for weight loss, smoking history, breast masses, or hematuria.

• Lymphoma: Can cause calcitriol-mediated hypercalcemia. Examine for lymphadenopathy and consider chest/abdominal imaging 2.

Key distinguishing feature: PTH should be suppressed (low) in malignancy-related hypercalcemia 1.

2. Primary Hyperparathyroidism (PHPT)

PHPT is the most common cause in ambulatory patients and should be suspected when 1, 4:

• PTH is elevated or inappropriately "normal" (not suppressed) in the setting of hypercalcemia
• History of renal stones, peptic ulcer disease, or postmenopausal status
• Chronic, stable mild hypercalcemia rather than acute severe elevation
• Family history of hyperparathyroidism or MEN syndromes
• Hypertension is present (cardiovascular morbidity is increased in PHPT) 1

Critical measurements 1, 5:

• Measure PTH and calcium on the same sample
• Calculate fractional excretion of calcium (FeCa): >2% indicates PHPT vs. familial hypocalciuric hypercalcemia
• Check 24-hour urine calcium (typically elevated in PHPT)
• Measure serum phosphate (often low in PHPT)

3. Tertiary Hyperparathyroidism in Chronic Kidney Disease

In patients with pre-existing renal failure, long-standing secondary hyperparathyroidism can progress to autonomous parathyroid function (tertiary HPT) with hypercalcemia 4. This is particularly relevant if the patient has been on dialysis or has advanced CKD.

4. Sarcoidosis

Non-PTH-dependent hypercalcemia with renal impairment should raise suspicion for sarcoidosis 6, 7. Look for:

• Elevated serum angiotensin-converting enzyme (ACE)
• Mediastinal/hilar lymphadenopathy on chest imaging
• Elevated 1,25-dihydroxyvitamin D (calcitriol)
• PTH should be suppressed
• Consider lymph node or renal biopsy showing non-caseating granulomas

Algorithmic Diagnostic Approach

Step 1: Measure PTH Level Simultaneously with Calcium

If PTH is LOW or suppressed:

• Malignancy workup: Check PTHrP, serum/urine protein electrophoresis, free light chains, chest/abdominal CT
• Vitamin D excess: Check 25-OH vitamin D and 1,25-dihydroxyvitamin D levels
• Sarcoidosis: Check ACE level, chest imaging, consider tissue biopsy
• Immobilization: Relevant in bedridden patients 8

If PTH is ELEVATED or inappropriately normal:

• Primary hyperparathyroidism: Calculate FeCa (>2% confirms PHPT), check 24-hour urine calcium
• Tertiary hyperparathyroidism: Consider if chronic renal failure pre-exists
• Familial hypocalciuric hypercalcemia: FeCa <1%, family history, mild asymptomatic hypercalcemia 1

Step 2: Assess Renal Function Context

• Pre-existing CKD: Consider tertiary HPT or medication effects (vitamin D, calcium supplements causing milk-alkali syndrome) 9
• Acute kidney injury: Hypercalcemia itself causes renal vasoconstriction and can precipitate AKI; malignancy (especially myeloma with cast nephropathy) is critical to exclude 10, 6

Step 3: Characterize Bone Involvement

• Lytic lesions on imaging: Think multiple myeloma, metastatic cancer, or brown tumors from severe hyperparathyroidism 4
• Diffuse osteopenia/osteoporosis: More consistent with PHPT
• "Salt and pepper" skull, "rugger jersey" spine: Classic for severe hyperparathyroidism 11

Step 4: Rule Out Confounding Factors 4, 1, 4

Before finalizing diagnosis, exclude:

• Vitamin D deficiency (can mask hyperparathyroidism)
• Medications: Thiazide diuretics (can unmask PHPT), lithium (causes hyperparathyroidism), calcium/vitamin D supplements (milk-alkali syndrome)
• Malabsorption states: Bariatric surgery, celiac disease
• Inadequate calcium intake: Can cause secondary hyperparathyroidism

Critical Pitfalls to Avoid

1. Do not rely solely on PTH levels: A "normal" PTH in the setting of hypercalcemia is pathological and suggests PHPT 5, 12. The PTH should be suppressed if hypercalcemia is from another cause.

2. Do not assume multiple myeloma based on CRAB features alone: Diffuse large B-cell lymphoma and other malignancies can present identically 3. Always confirm with protein studies and bone marrow biopsy.

3. Do not overlook sarcoidosis: In the absence of pulmonary symptoms, hypercalcemia with renal failure can be the initial presentation 7. Check ACE levels and consider tissue diagnosis.

4. Measure calcium and PTH on the same blood sample: Temporal discordance can lead to misdiagnosis 5.

5. Calculate FeCa, not just 24-hour urine calcium: This better discriminates PHPT from familial hypocalciuric hypercalcemia, especially in the setting of renal impairment 5.

Immediate Management Considerations

While establishing diagnosis, hypercalcemia of malignancy requires urgent treatment with IV hydration and bisphosphonates (or denosumab if renal failure is severe) to prevent life-threatening complications 2, 13. PHPT may require parathyroidectomy, particularly if causing end-stage renal disease 11.